InsidersTradesSigma
Track the 진양제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 진양제약 has logged 3 public disclosures. Market capitalisation: €49bn. The latest transaction was reported on 5 June 2026 (Other). Among the most active insiders: 최윤환. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.